344 related articles for article (PubMed ID: 34746014)
21. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
22. Advances in tumor vascular growth inhibition.
Zhang K; Shi Y; Jin Z; He J
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38504070
[TBL] [Abstract][Full Text] [Related]
23. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis.
Larionova I; Kazakova E; Gerashchenko T; Kzhyshkowska J
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209679
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumorigenic and anti-angiogenic effects of natural conifer Abies sibirica terpenoids in vivo and in vitro.
Nevzorova YA; Grossmann J; Trautwein C
Biomed Pharmacother; 2017 May; 89():386-395. PubMed ID: 28254663
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
26. Compensatory angiogenesis and tumor refractoriness.
Gacche RN
Oncogenesis; 2015 Jun; 4(6):e153. PubMed ID: 26029827
[TBL] [Abstract][Full Text] [Related]
27. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
Gacche RN; Meshram RJ
Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
[TBL] [Abstract][Full Text] [Related]
28. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential.
Lahooti B; Poudel S; Mikelis CM; Mattheolabakis G
Front Oncol; 2021; 11():705634. PubMed ID: 34956857
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
Merk H; Zhang S; Lehr T; Müller C; Ulrich M; Bibb JA; Adams RH; Bracher F; Zahler S; Vollmar AM; Liebl J
Oncotarget; 2016 Feb; 7(5):6088-104. PubMed ID: 26755662
[TBL] [Abstract][Full Text] [Related]
30. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy.
Tiwari A; Mukherjee B; Dixit M
Curr Cancer Drug Targets; 2018; 18(3):266-277. PubMed ID: 28669338
[TBL] [Abstract][Full Text] [Related]
32. New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment.
Javan MR; Khosrojerdi A; Moazzeni SM
Front Oncol; 2019; 9():840. PubMed ID: 31555593
[TBL] [Abstract][Full Text] [Related]
33. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling.
Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H
Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479
[TBL] [Abstract][Full Text] [Related]
34. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
Parmar D; Apte M
Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model.
Li D; Finley SD
Front Physiol; 2019; 10():823. PubMed ID: 31379588
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
Yetkin-Arik B; Kastelein AW; Klaassen I; Jansen CHJR; Latul YP; Vittori M; Biri A; Kahraman K; Griffioen AW; Amant F; Lok CAR; Schlingemann RO; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188446. PubMed ID: 33058997
[TBL] [Abstract][Full Text] [Related]
38. Anti-angiogenic therapy as a cancer treatment paradigm.
Dhanabal M; Jeffers M; Larochelle WJ
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):115-30. PubMed ID: 15777219
[TBL] [Abstract][Full Text] [Related]
39. Natural products as anti-invasive and anti-metastatic agents.
Jiang YL; Liu ZP
Curr Med Chem; 2011; 18(6):808-29. PubMed ID: 21182481
[TBL] [Abstract][Full Text] [Related]
40. Antitumor and anti-angiogenic potentials of isolated crude saponins and various fractions of Rumex hastatus D. Don.
Ahmad S; Ullah F; Ayaz M; Zeb A; Ullah F; Sadiq A
Biol Res; 2016 Mar; 49():18. PubMed ID: 26969307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
